ClassID:

20523

A61K31/7048 - page 12 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin

Recent Application in this class:
#3301
20120015057
2012-01-19

Polyphenol composition

#3302
20120010163
2012-01-12

Antibacterial compounds, methods of making them, and uses thereof

#3303
20120004200
2012-01-05

TOPICAL PHARMACEUTICAL COMPOSITION CONTAINING A WATER-SENSITIVE ACTIVE PRINCIPLE

#3304
20120004193
2012-01-05

PROCESS FOR PRODUCTION OF ORALLY INGESTIBLE COMPOSITION CONTAINING ARABINOFURANOSYL VITEXIN, AND USE OF THE COMPOSITION

#3305
20120004177
2012-01-05

Compositions and methods of delivery of pharmacological agents

#3306
20120003337
2012-01-05

HEALTH SUPPLEMENTS CONTAINING PHYTO-OESTROGENS, ANALOGUES OR METABOLITES THEREOF

#3307
20120003312
2012-01-05

Multilayer Minitablets with Different Release Rates

#3308
20120003288
2012-01-05

DISPERSION COMPOSITION AND METHOD FOR MANUFACTURING DISPERSION COMPOSITION

#3309
20110319351
2011-12-29

TREATING CANCER WITH CARDIAC GLYCOSIDES

#3310
20110318309
2011-12-29

Equol-producing bacterium and use thereof

#3311
20110312988
2011-12-22

SNS-595 and methods of using the same

#3312
20110312904
2011-12-22

Compounds, compositions and methods for reducing toxicity and treating or preventing diseases

#3313
20110311592
2011-12-22

Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds

#3314
20110306571
2011-12-15

Method of treating colorectal cancer that expresses a mutated APC gene by administering erythromycin or tylosin

#3315
20110306570
2011-12-15

Na/K-Atpase Expression as an Indicator for the Treatment of Cancer

#3316
20110305782
2011-12-15

METHODS OF CHOLESTEROL REDUCTION USING ISOFLAVONES

#3317
20110301248
2011-12-08

Compositions and methods of delivery of pharmacological agents

#3318
20110301106
2011-12-08

Use of icariside II in manufacture of products for preventing or treating male or female sexual dysfunction

#3319
20110300245
2011-12-08

Topical, palatable, anti-inflammatory and analgesic for specific application to intraoral, gingival and extraoral areas correlated with, and related to, the trigeminal nerve and its nerve branches and plexus. To mitigate, attenuate or prevent migraine-type headache, cluster-type headache, tension-type headache, post-traumatic headache, atypical facial pain and cervical muscle spasm as well as other idiopathic head or facial pain or discomfort, associated with, or exacerbated by, inflammation

#3320
20110294751
2011-12-01

High dosage doramectin formulation

#3321
20110294726
2011-12-01

ANTIBIOTIC THERAPY TO REDUCE THE LIKELIHOOD OF DEVELOPING POST-INFECTIOUS IRRITABLE BOWEL SYNDROME

#3322
20110293747
2011-12-01

COLON CLEANSING SOLUTION

#3323
20110293696
2011-12-01

Compositions and methods for treating bruises

#3324
20110288038
2011-11-24

Hesperidin-containing composition

#3325
20110287103
2011-11-24

Sustained-release formulations of topiramate

#3326
20110287099
2011-11-24

Sustained-release formulations of topiramate

#3327
20110287081
2011-11-24

BOLUS

#3328
20110287074
2011-11-24

Antimicrobial Compositions, Methods of Manufacture Thereof and Articles Comprising the Same

#3329
20110281935
2011-11-17

Combination therapy based on SRC and aurora kinase inhibition for the treatment of cancer

#3330
20110281920
2011-11-17

INJECTABLE PARASITICIDAL FORMULATIONS OF LEVAMISOLE AND MACROCYCLIC LACTONES

#3331
20110281833
2011-11-17

Composition for the treatment of ear infections and method

#3332
20110281810
2011-11-17

Composition

#3333
20110281808
2011-11-17

Composition and Method for Increasing Pre Workout Thermogenics

#3334
20110280923
2011-11-17

Bolus devices for the delivery of active agents to animals

#3335
20110280904
2011-11-17

Generation of virus-like particles and use as panfilovirus vaccine

#3336
20110275696
2011-11-10

Thioxanthone-based autophagy inhibitor therapies to treat cancer

#3337
20110275582
2011-11-10

Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice

#3338
20110275558
2011-11-10

Lanthionine synthetase component C-like proteins as molecular targets for preventing and treating diseases and disorders

#3339
20110274631
2011-11-10

AVERMECTIN/METRONIDAZOLE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA

#3340
20110269704
2011-11-03

METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY

#3341
20110268825
2011-11-03

Compositions that include anthocyanidins and methods of use

#3342
20110268720
2011-11-03

Formulations of 5-fluorocytosine and uses thereof

#3343
20110263524
2011-10-27

SNS-595 AND METHODS OF USING THE SAME

#3344
20110263522
2011-10-27

ANTITUMOUR COMPOSITIONS CONTAINING TAXANE DERIVATIVES

#3345
20110262550
2011-10-27

METHOD FOR TREATING A SKIN AILMENT

#3346
20110262535
2011-10-27

Low Dose Topiramate / Phentermine Composition and Methods of Use Thereof

#3347
20110262485
2011-10-27

STING (STIMULATOR OF INTERFERON GENES), A REGULATOR OF INNATE IMMUNE RESPONSES

#3348
20110256248
2011-10-20

Antioxidant compositions and methods thereto

#3349
20110251150
2011-10-13

Targeting MicroRNAs For The Treatment Of Liver Cancer

#3350
20110251145
2011-10-13

Phytoestrogenic compositions for preventing or treating symptoms associated with menopause

#3351
20110251144
2011-10-13

MOLECULAR MODULATORS OF THE WNT/BETA-CATENIN PATHWAY

#3352
20110251143
2011-10-13

STABLE ELSAMITRUCIN SALT FORMULATIONS

#3353
20110250297
2011-10-13

Treatment of Hyperproliferative Disorders Using Cardiac Glycosides

#3354
20110250269
2011-10-13

Highly efficient and long-acting slow-release formulation of poorly soluble drugs and preparation method thereof

#3355
20110250228
2011-10-13

Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin

#3356
20110250191
2011-10-13

Composition for enhancing physical performance

#3357
20110245501
2011-10-06

Substituted Tetracycline Compounds as Synergistic Antifungal Agents

#3358
20110245333
2011-10-06

IDENTIFICATION OF FREE-B-RING FLAVONOIDS AS POTENT COX-2 INHIBITORS

#3359
20110245191
2011-10-06

Parasiticidal compositions comprising multiple active agents, methods and uses thereof

#3360
20110244043
2011-10-06

Controlled releasing composition

#3361
20110237546
2011-09-29

Method for treating a mammal by administration of a compound having the ability to release CO

#3362
20110237534
2011-09-29

Methods for treating gastrointestinal diseases

#3363
20110237533
2011-09-29

NOVEL POLYPHENOL COMPOUND

#3364
20110237497
2011-09-29

COMPOSITIONS OF A V-ATPASE INHIBITOR IN COMBINATION WITH A GLUCOCORTICOID RECEPTOR LIGAND AND METHODS OF USE

#3365
20110236510
2011-09-29

PREGNANE GLYCOSIDE COMPOSITIONS AND CARALLUMA EXTRACT PRODUCTS AND USES THEREOF

#3366
20110236384
2011-09-29

DIRECT DRUG DELIVERY SYSTEM BASED ON THERMALLY RESPONSIVE BIOPOLYMERS

#3367
20110224158
2011-09-15

Esterified α-galactosylceramide

#3368
20110223234
2011-09-15

Process for manufacturing chewable dosage forms for drug delivery and products thereof

#3369
20110218163
2011-09-08

Paeoniflorin preparations and uses thereof for fat reduction

#3370
20110218161
2011-09-08

Cycloastragenol monoglucoside, preparation, pharmaceutical composition and application thereof

#3371
20110217398
2011-09-08

Extract of aerial parts of oats harvested before ear emergence

#3372
20110217359
2011-09-08

PHARMACEUTICAL COMPOSITION FOR THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF DECUBITI AND FIRST DEGREE BURNS AND TREATMENT METHOD

#3373
20110217300
2011-09-08

Quinazolinone Compounds and Methods of Use Thereof

#3374
20110213037
2011-09-01

Methods for concomitant administration of colchicine and macrolide antibiotics

#3375
20110212913
2011-09-01

THERAPEUTIC COMPOSITIONS COMPRISING PHENOLIC ACIDS FOR TREATING CONDITIONS RELATED TO INAPPROPRIATE PLATELET AGGREGATION

#3376
20110207825
2011-08-25

Methods for concomitant administration of colchicine and macrolide antibiotics

#3377
20110207806
2011-08-25

Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care

#3378
20110207718
2011-08-25

COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC DISORDERS

#3379
20110207684
2011-08-25

Low side effect pharmaceutical composition containing isoniazid

#3380
20110207682
2011-08-25

Pharmaceutical composition useful for the treatment of peptic ulcer diseases

#3381
20110206794
2011-08-25

FRUIT EXTRACTS

#3382
20110206786
2011-08-25

Acai and Iridoid Based Formulations

#3383
20110201567
2011-08-18

Ivermectin antagonizes ethanol inhibition in P2X4 receptors

#3384
20110201566
2011-08-18

Methods for treating resistant diseases using triazole containing macrolides

#3385
20110201565
2011-08-18

LUTEOLIN AND DIOSMIN/DIOSMETIN AS NOVEL STAT3 INHIBITORS FOR TREATING AUTISM

#3386
20110196028
2011-08-11

PCK ACTIVATION AS A MEANS FOR ENHANCING sAPPa SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS

#3387
20110195920
2011-08-11

Biodefenses using triazole-containing macrolides

#3388
20110195919
2011-08-11

COMBINATION THERAPY FOR ACNE VULGARIS COMPRISING ADMINISTRATION OF ADAPALENE 0.3% GEL AND CLINDAMYCIN/BENZOYL PEROXIDE GEL

#3389
20110195138
2011-08-11

Anti-inflammatory cranberry flavonol extract preparations

#3390
20110195066
2011-08-11

QUINOLINE INHIBITORS OF TYROSINE KINASE

#3391
20110190396
2011-08-04

Methods for concomitant administration of colchicine and macrolide antibiotics

#3392
20110189258
2011-08-04

Method and compositions for inhibition of double stranded DNA viruses

#3393
20110189152
2011-08-04

Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency

#3394
20110186971
2011-08-04

METHOD OF MAKING DENSE, CONFORMAL, ULTRA-THIN CAP LAYERS FOR NANOPOROUS LOW-K ILD BY PLASMA ASSISTED ATOMIC LAYER DEPOSITION

#3395
20110184337
2011-07-28

Methods and devices for denervation

#3396
20110184158
2011-07-28

Hydrates of erythromycin salts, preparation and use thereof

#3397
20110182912
2011-07-28

Methods for renal denervation

#3398
20110178049
2011-07-21

AVERMECTIN/HYDROCORTISONE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN. E.G., ROSACEA

#3399
20110177182
2011-07-21

Muscadine compositions with improved anti-oxidant activity

#3400
20110172172
2011-07-14

Method of treating neurological conditions with cardiac glycoside

#3401
20110171329
2011-07-14

METHOD FOR TREATMENT OF NEURAL INJURIES

#3402
20110171269
2011-07-14

Method for manufacturing uniform size polymeric nanoparticles containing poorly soluble drugs

#3403
20110171232
2011-07-14

Methods of treating autoimmune diseases caused by small intestinal bacterial overgrowth

#3404
20110171159
2011-07-14

Glycoside derivatives and uses thereof

#3405
20110166219
2011-07-07

Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin

#3406
20110166090
2011-07-07

18-Membered Macrocycles and Analogs Thereof

#3407
20110165272
2011-07-07

ANTIALLERGIC COMPOSITION

#3408
20110165264
2011-07-07

Use of cilastatin to reduce nephrotatoxicity of various compounds

#3409
20110165154
2011-07-07

COMPOSITIONS AND METHODS USING ANTI-CS1 ANTIBODIES TO TREAT MULTIPLE MYELOMA

#3410
20110165100
2011-07-07

COMPOSITIONS COMPRISING AVERMECTIN/AZELAIC ACID COMPOUNDS USEFUL FOR TREATING, E.G., ROSACEA

#3411
20110160156
2011-06-30

Pharmaceutical Composition for the Eradication of Helicobacter Pylori and Preparation Method Thereof

#3412
20110160155
2011-06-30

Composition and use of a long-acting oral bioadhesive endoparasiticide gel based on doramectin

#3413
20110160146
2011-06-30

Conjungation of Small Molecules to Octaarginine Transporters for Overcoming Multi-Drug Resistance

#3414
20110152211
2011-06-23

Methods and formulations for reducing amphotericin B treatment side effects

#3415
20110152210
2011-06-23

POLYPHENOL COMPOUNDS FOR INHIBITING PROTEASOME AND USES THEREOF

#3416
20110144127
2011-06-16

AGENTS FOR TREATMENT OF GLAUCOMATOUS RETINOPATHY AND OPTIC NEUROPATHY

#3417
20110144045
2011-06-16

USE OF FUMAGILLIN AND THE DERIVATIVES THEREOF TO INCREASE THE BIOAVAILABILITY OF THE MACROCYCLIC LACTONES

#3418
20110142973
2011-06-16

Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus

#3419
20110142966
2011-06-16

Aqueous extracts of spp. kinsenoside and pharmaceutical compositions useful for hepatoprotection

#3420
20110135770
2011-06-09

APPLES WITH HIGH POLYPHENOLIC CONTENT

#3421
20110130355
2011-06-02

USE OF SOPHORICOSIDE IN THE MANUFACTURE OF MEDICAMENTS

#3422
20110129463
2011-06-02

Quinazolin-4(3A)-One Derivatives and Methods of Use Thereof

#3423
20110124720
2011-05-26

COMPOSITIONS AND METHODS FOR TREATING IMMUNE DISORDERS

#3424
20110124719
2011-05-26

COMPOSITION FOR PROMOTING PRODUCTION OF HYALURONIC ACID CONTAINING KAEMPFEROL AND QUERCETIN

#3425
20110124681
2011-05-26

TOPICAL AND INJECTABLE FORMULATIONS COMPRISING LEUKOTRIENE RECEPTOR ANTAGONIST AND USES THEREOF

#3426
20110124577
2011-05-26

PREPARATION FOR ORAL ADMINISTRATION COMPRISES QUERCETIN GLYCOSIDE AND A WATER-BASED SOLVENT EXTRACT OF CARTILAGE CONTAINING CHONDROITIN SULFATE

#3427
20110123653
2011-05-26

COMPOSITIONS AND METHODS FOR OPTIMIZING EXERCISE RECOVERY

#3428
20110123437
2011-05-26

COMBINATORIAL THERAPIES FOR THE TREATMENT OF NEOPLASIAS USING THE OPIOID GROWTH FACTOR RECEPTOR

#3429
20110118212
2011-05-19

Pestcidal active mixtures comprising isoxazoline compounds I

#3430
20110118201
2011-05-19

Glutathione production enhancer, prophylactic/therapeutic agent for diseases caused by glutathione deficiency, and food, beverage and feed

#3431
20110111072
2011-05-12

Methods for preventing and treating neurodegenerative diseases

#3432
20110110885
2011-05-12

Bioactive depside and anthocyanin compounds, compositions, and methods of use

#3433
20110105386
2011-05-05

USE OF ANTIMICROBIAL POLYMERS FOR RE-SENSITIZATION OF MICROORGANISMS UPON EMERGENCE OF RESISTANCE TO ANTI-MICROBIAL AGENTS

#3434
20110104251
2011-05-05

Cosmetic composition and method for retarding hair growth

#3435
20110104235
2011-05-05

Compositions and methods for treating conditions of the nail unit

#3436
20110104050
2011-05-05

Compositions and methods for identifying and targeting cancer cells of alimentary canal origin

#3437
20110098349
2011-04-28

CATHECHINS FOR THE TREATMENT OF SYSTEMIC AA AMYLOIDOSIS

#3438
20110098266
2011-04-28

Method of administering an injectable antibiotic to an animal

#3439
20110098240
2011-04-28

PHARMACEUTICAL COMPOSITION COMPRISING A SGLT2 INHIBITOR IN COMBINATION WITH A DPP-IV INHIBITOR

#3440
20110091726
2011-04-21

Particulate composition containing anhydrous crystalline 2-O-alpha-D-glucosyl-L-ascorbic acid, process for producing the same, and uses thereof

#3441
20110091523
2011-04-21

Cochleate compositions directed against expression of proteins

#3442
20110091421
2011-04-21

Methods of novel therapeutic candidate identification through gene expression analysis in vascular-related diseases

#3443
20110086112
2011-04-14

Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same

#3444
20110086100
2011-04-14

Polyethylene glycol aerogels for targeted delivery of pharmaceutical drubs

#3445
20110086088
2011-04-14

Compositions and methods for treatment of mammalian skin

#3446
20110086064
2011-04-14

COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN

#3447
20110082199
2011-04-07

Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissues

#3448
20110082098
2011-04-07

NOVOBIOCIN ANALOGUES AND TREATMENT OF POLYCYSTIC KIDNEY DISEASE

#3449
20110082076
2011-04-07

Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use

#3450
20110081366
2011-04-07

IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES

#3451
20110081356
2011-04-07

Anti-cancer drug

#3452
20110081322
2011-04-07

Elastin producing fibroblast formulations and methods of using the same

#3453
20110076328
2011-03-31

Compositions for the treatment of hair loss

#3454
20110076308
2011-03-31

Micelle encapsulation of therapeutic agents

#3455
20110076278
2011-03-31

Modulators of Hypoxia Inducible Factor-1 and Related Uses for the Treatment of Ocular Disorders

#3456
20110076276
2011-03-31

Pyrimidine derivatives as HIV reverse transcriptase inhibitors

#3457
20110071096
2011-03-24

Macrolides Having Antibiotic Activity

#3458
20110071095
2011-03-24

Compositions and methods for increasing telomerase activity

#3459
20110065731
2011-03-17

Uses of DPP-IV inhibitors

#3460
20110065718
2011-03-17

Antifungal once-a-day product, use and formulation thereof

#3461
20110065662
2011-03-17

Compounds, compositions, and methods for protecting brain health in neurodegenerative disorders

#3462
20110065657
2011-03-17

Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases

#3463
20110064708
2011-03-17

Methods and compositions for the dietary management of autoimmune disorders

#3464
20110060323
2011-03-10

Cryo-medical injection device and method of use

#3465
20110059913
2011-03-10

COMPOSITIONS AND METHODS FOR THE TREATMENT OF GASTROINTESTINAL INDICATIONS

#3466
20110059170
2011-03-10

Methods for administering weight loss medications

#3467
20110059136
2011-03-10

Methods and compositions for treating inflammatory bowel disease

#3468
20110059117
2011-03-10

Liquid compositions capable of foaming and including active agents, and methods for making or developing same

#3469
20110053874
2011-03-03

USE OF FLAVONOIDE COMPOUNDS FOR THE PROPHYLAXIS AND THERAPY OF ISCHAEMIC OR INFLAMMATORY HEART AND CARDIOVASCULAR DISEASES

#3470
20110053872
2011-03-03

Pharmaceutical Composition For Preventing And Treating Diabetic Nephropathy And The Preparation Method Thereof

#3471
20110053240
2011-03-03

DNA DAMAGING AGENTS IN COMBINATION WITH TYROSINE KINASE INHIBITORS

#3472
20110052515
2011-03-03

AVERMECTIN/BENZOYL PEROXIDE COMPOSITIONS FOR TREATING AFFLICTION OF THE SKIN, E.G., ROSACEA

#3473
20110046215
2011-02-24

ABNORMAL INTRAOCULAR PRESSURE TREATMENT

#3474
20110046212
2011-02-24

USE OF OLEUROPEIN AND DERIVATIVES IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS AND PATHOLOGIES ASSOCIATED WITH PROTEIN AGGREGATION PHENOMENA

#3475
20110046087
2011-02-24

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#3476
20110046081
2011-02-24

Classical cannabinoid metabolites and methods of use thereof

#3477
20110046076
2011-02-24

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#3478
20110046072
2011-02-24

SOLID PHARMACEUTICAL FORMULATION WITH DELAYED RELEASE

#3479
20110045108
2011-02-24

ANTI-DIABETIC EXTRACT OF HONEYBUSH

#3480
20110045050
2011-02-24

NANOEMULSION FORMULATIONS FOR DIRECT DELIVERY

#3481
20110044944
2011-02-24

Anti-inflammatory compositions for treating brain inflammation

#3482
20110039792
2011-02-17

Selective Targeting Agents for Mitochondria

#3483
20110039790
2011-02-17

Enhanced ocular neuroprotection and neurostimulation

#3484
20110034378
2011-02-10

Pharmaceutical Combinations Comprising Specified Age Breaker and Further Drugs, I.A. Antihypertensive Drugs, Antidiabetic Drugs Etc.

#3485
20110033525
2011-02-10

Diterpene Glycosides as Natural Solubilizers

#3486
20110033402
2011-02-10

Solubilized benzoyl small molecule

#3487
20110033395
2011-02-10

AVERMECTIN/METRONIDAZOLE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA

#3488
20110028905
2011-02-03

Preparation for body surface application and preparation for body surface application-holding sheet

#3489
20110027356
2011-02-03

Combination of Oral Medicaments Bonded by a Wrapping

#3490
20110021449
2011-01-27

Macrolides and uses of macrolides

#3491
20110020478
2011-01-27

METHOD FOR TREATING NEURAL INJURIES

#3492
20110020306
2011-01-27

Probiotic, lactic acid-producing bacteria and uses thereof

#3493
20110020305
2011-01-27

Probiotic, lactic acid-producing bacteria and uses thereof

#3494
20110008307
2011-01-13

Cephalotaxine Alkaloid Compositions and Uses Thereof

#3495
20110003763
2011-01-06

AVERMECTIN/BENZOYL PEROXIDE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA

#3496
20110003762
2011-01-06

Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia

#3497
20110003386
2011-01-06

Identification and characterization of cancer stem cells and methods of use

#3498
20100331399
2010-12-30

Polyphenol extraction process

#3499
20100323978
2010-12-23

Non-aqueous oil delivery system for ophthalmic drugs

#3500
20100323046
2010-12-23

Uses of hibiscus, in particular pharmaceutical uses

#3501
20100317605
2010-12-16

THE USE OF EPIMEDIUM FLAVONES AND EFFECTIVE COMPONENTS THEREOF FOR THE PREPARATION OF MEDICAMENTS OF PROMOTING PROLIFERATIONS AND DIFFERENTIATIONS OF NERVE CELLS

#3502
20100317541
2010-12-16

Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside

#3503
20100312525
2010-12-09

Ribosome Structure and Protein Synthesis Inhibitors

#3504
20100311595
2010-12-09

Processes for the preparation of lipophilic drug delivery vehicles

#3505
20100310684
2010-12-09

Methods for treating and preventing mucositis

#3506
20100310680
2010-12-09

COMPOSITION AND METHOD FOR TREATING ACNE

#3507
20100303907
2010-12-02

Standardized plant extract, process for obtaining the same and uses thereof

#3508
20100298412
2010-11-25

Disulfide chemotherapeutic agents and methods of use thereof

#3509
20100298250
2010-11-25

Compositions and methods for extracting and using phytochemicals for the treatment of influenza

#3510
20100298248
2010-11-25

Biologically active macrolides, compositions, and uses thereof

#3511
20100298243
2010-11-25

COMBINATION THERAPY WITH SGLT-2 INHIBITORS AND THEIR PHARMACEUTICAL COMPOSITIONS

#3512
20100292178
2010-11-18

Method of treating non-insulin dependent diabetes mellitus and related complications

#3513
20100292177
2010-11-18

Methods of treatment using combination therapy

#3514
20100286256
2010-11-11

Compositions and methods for therapy for diseases characterized by defective chloride transport

#3515
20100286075
2010-11-11

AMPHIPHILIC BLOCK COPOLYMER MICELLE COMPOSITION CONTAINING TAXANE AND MANUFACTURING PROCESS OF THE SAME

#3516
20100285141
2010-11-11

COMPOSITIONS AND METHODS FOR ENHANCING THE ACTIVITY OF PODOPHYLLOTOXIN

#3517
20100285138
2010-11-11

Compositions comprising nanoparticles and apoptotic agents and methods of use

#3518
20100280231
2010-11-04

WHITENING AGENT COMPRISING EQUOL OR ITS SACCHARIDE DERIVATIVE AS AN EFFECTIVE INGREDIENT

#3519
20100280230
2010-11-04

Method of preparing clarithromycin

#3520
20100279961
2010-11-04

PHARMACEUTICAL COMPOSITION HAVING A TRIHYDROXY-CHROMENONE DERIVATIVE

#3521
20100279957
2010-11-04

PREDICTING RESPONSIVENESS TO CANCER THERAPEUTICS

#3522
20100273728
2010-10-28

Formulations for the oral administration of therapeutic agents and related methods

#3523
20100273726
2010-10-28

METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS ACTIVE METABOLITES ISOLATED FROM LAURUS NOBILIS AND COMBINATIONS THEREOF

#3524
20100267814
2010-10-21

Targeting microRNAs for the treatment of liver cancer

#3525
20100267652
2010-10-21

Method of inhibiting ABCG2 and related treatments

#3526
20100266637
2010-10-21

Method of preventing early infections

#3527
20100266544
2010-10-21

Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability

#3528
20100261663
2010-10-14

Compositions Containing Harpagoside and Paeoniflorin and Methods for Treatment of Conditions Associated with Pain, Inflammation, Arthritis and Symptoms Thereof

#3529
20100260719
2010-10-14

Methods for treatment of hepatocellular carcinoma using 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione

#3530
20100256345
2010-10-07

Method for glycosylation of flavonoid compounds

#3531
20100256079
2010-10-07

Eriocitrin-containing material, method for production of the eriocitrin-containing material, and food, beverage, pharmaceutical preparation and cosmetic each comprising the eriocitrin-containing material

#3532
20100249050
2010-09-30

EPOTHILONE GLYCOSIDE AND USE THEREOF

#3533
20100240603
2010-09-23

EXPRESSION INHIBITOR OF NUCLEAR TRANSCRIPTION FACTOR AP-1 AND PHARMACEUTICALS AND PRODUCTS USING THE SAME

#3534
20100240601
2010-09-23

Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients

#3535
20100239686
2010-09-23

Method for making nanolipidic particles

#3536
20100226996
2010-09-09

Compositions and methods of delivery of pharmacological agents

#3537
20100222290
2010-09-02

Methods for concomitant administration of colchicine and macrolide antibiotics

#3538
20100221351
2010-09-02

Controlled Drug Delivery Using a Thermally Responsive Nanocapsule to Augment Cryoablation

#3539
20100221298
2010-09-02

Galenical system for active transport, method for preparation and use

#3540
20100221251
2010-09-02

Compositions and methods for treatment of cancer

#3541
20100221220
2010-09-02

THERAPEUTICS FOR CANCER USING 3-BROMOPYRUVATE AND OTHER SELECTIVE INHIBITORS OF ATP PRODUCTION

#3542
20100216874
2010-08-26

HYDROXYTYROSOL-RICH COMPOSITION FROM OLIVE VEGETATION WATER AND METHOD OF USE THEREOF

#3543
20100216697
2010-08-26

Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition

#3544
20100215739
2010-08-26

Low dose topiramate/phentermine composition and methods of use thereof

#3545
20100215716
2010-08-26

COMPOSITIONS AND METHODS FOR COATING ORTHOPEDIC IMPLANTS

#3546
20100215633
2010-08-26

Method for feeding dairy cows and dairy goats supplements to increase the C2 hxroylated estrogen (C2) to C16 hydroxlated estrogen (C16) ratio secreted in their urine

#3547
20100210589
2010-08-19

METHOD FOR IMPROVING HEPATIC FUNCTION

#3548
20100210576
2010-08-19

Polyene diester antibiotics

#3549
20100210575
2010-08-19

STRUCTURING EFFECT OF CHOLESTEROL IN PEG-PHOSPHOLIPID MICELLES, DRUG DELIVERY OF AMPHOTERICIN B, AND COMBINATION ANTIFUNGALS

#3550
20100210546
2010-08-19

COMBINATION CHEMOTHERAPY WITH CHLOROTOXIN

#3551
20100209507
2010-08-19

Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions

#3552
20100209506
2010-08-19

PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF

#3553
20100204253
2010-08-12

Ribosome structure and protein synthesis inhibitors

#3554
20100203122
2010-08-12

Delivery system for remote treatment of an animal

#3555
20100197917
2010-08-05

Coumarin derivatives useful as TNFα inhibitors

#3556
20100197779
2010-08-05

Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury

#3557
20100197778
2010-08-05

PROANTHOCYANIDINS FOR THE TREATMENT OF AMYLOID AND ALPHA-SYNUCLEIN DISEASES

#3558
20100197766
2010-08-05

Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses thereof in the treatment of cancer

#3559
20100197624
2010-08-05

Anthelmintic combination

#3560
20100197623
2010-08-05

Anti-infammatory macrolide

#3561
20100197621
2010-08-05

METHODS OF REDUCING THE PROLIFERATION AND VIABILITY OF MICROBIAL AGENTS

#3562
20100197619
2010-08-05

Cyclin-dependent protein kinases inhibitors of flavonoid organic amine derivatives, synthesis and use thereof

#3563
20100197618
2010-08-05

Extract of . for reducing blood glucose and lipid levels and treating hematologic diseases, and methods for preparing the same

#3564
20100196490
2010-08-05

Compositions and methods of delivery of pharmacological agents

#3565
20100196369
2010-08-05

Methods for treatment of follicular lymphoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione

#3566
20100196331
2010-08-05

Compositions including anthocyanin or anthocyanidin for the prevention or treatment of articular cartilage-associated conditions

#3567
20100190735
2010-07-29

Mouthwash and Method of Using Same for the Treatment of Mucositis or Stomatitis

#3568
20100190733
2010-07-29

Methods of Treating Muscular Dystrophies

#3569
20100189702
2010-07-29

COMPOSITIONS AND METHODS FOR RESTORING BACTERIAL FLORA

#3570
20100184844
2010-07-22

Inhibition of Bacterial Protein Production by Polyvalent Oligonucleotide Modified Nanoparticle Conjugates

#3571
20100179098
2010-07-15

FUROST-5-ENE-3, 22, 26-TRIOL GLYCOSIDE COMPOUND FOR PREVENTING AND TREATMENT CANCER

#3572
20100178305
2010-07-15

ULTRASONIC NANOTHERAPY OF SOLID TUMORS WITH BLOCK COPOLYMERS STABILIZED PERFLUOROCARBON NANODROPLETS

#3573
20100174076
2010-07-08

Coumarin derivatives useful as TNFα inhibitors

#3574
20100173858
2010-07-08

Compositions to treat bacterial and inflammatory affections in pet animals dosage form and method to treat pet animals

#3575
20100173857
2010-07-08

Spinosyns for wound healing

#3576
20100172964
2010-07-08

Vesicle useful for external preparation for skin, and external preparation for skin comprising the vesicle

#3577
20100168223
2010-07-01

7-hydroxy chromones as potent antioxidants

#3578
20100168160
2010-07-01

Genipin derivatives and uses thereof

#3579
20100166846
2010-07-01

MANAGEMENT OF MYOCLONUS WITH ORAL LIPOSOMAL REDUCED GLUTATHIONE

#3580
20100160603
2010-06-24

METHOD FOR ALTERING MORPHOLOGY OF BLOCK COPOLYMER

#3581
20100160410
2010-06-24

USE OF PENTADIENOIC ACID DERIVATIVES FOR THE TREATMENT OF HYPERURICEMIA

#3582
20100160208
2010-06-24

Pharmaceutical composition

#3583
20100151006
2010-06-17

Cancer therapy sensitizer

#3584
20100150895
2010-06-17

Nutraceutical agent for attenuating the neurodegenerative process associated with Parkinson's disease

#3585
20100144859
2010-06-10

Dimeric avermectin and milbemycin derivatives

#3586
20100144658
2010-06-10

Antibiotics, bispolides A1, A2, and A3 as well as bispolides B1, B2a, B2b and B3 and processes for producing said antibiotics

#3587
20100143409
2010-06-10

Generation of virus-like particles and use as panfilovirus vaccines

#3588
20100137384
2010-06-03

Anthelmintic composition

#3589
20100137235
2010-06-03

Methods for Concomitant Administration of Colchicine and Macrolide Antibiotics

#3590
20100137232
2010-06-03

COMPOSITION COMPRISING A DIURETIC AND A CARDIAC GLYCOSIDE FOR THE TREATMENT OF DNA VIRAL INFECTIONS OF THE EYE

#3591
20100137228
2010-06-03

DRUGS, FOODS OR DRINKS WITH THE USE OF ALGAE-DERIVED PHYSIOLOGICALLY ACTIVE SUBSTANCES

#3592
20100136029
2010-06-03

Use of Tri-Substituted Glycerol Compounds for the Treatment of Hematological Malignancies

#3593
20100131258
2010-05-27

Method for identifying protein synthesis inhibitors by ribosome structure

#3594
20100130437
2010-05-27

Topical antibiotic composition for the prevention of Lyme disease

#3595
20100130436
2010-05-27

CO-ADMINISTRATION OF RANOLAZINE AND CARDIAC GLYCOSIDES

#3596
20100129467
2010-05-27

Nutritional supplement

#3597
20100129434
2010-05-27

COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUCORMYCOSIS AND OTHER FUNGAL DISEASES

#3598
20100125101
2010-05-20

Methods of using immunostimulatory nucleic acid molecules to treat allergic conditions

#3599
20100125051
2010-05-20

Parenteral formulations comprising sugar-based esters and ethers

#3600
20100124554
2010-05-20

REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS